TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 2 | -2 | 2 | 21 | 11 | -39 | 14 | 1 |
| P | %wins | 50 | 100 | 100 | 50 | 0 | 50 | 58 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/9/15 10:31 | 6/5/15 | REPH | Recro Pharma, Inc. | PA | Health | Drug | Pharmaceutical Preparations | Garner Charles | PA | O | CFO,Chie | P | 17 | 8.50 | 1 | 2 | 67 | 5 | D | 64 | 313 | 148 | 4 | 18 | 31 | 35 | -3 | 0 | 20 | 32 | -21 | -23 | |
5/15/14 19:58 | 5/15/14 | REPH | Recro Pharma, Inc. | PA | Health | Drug | Pharmaceutical Preparations | Garner Charles | PA | O | CFO,Chie | P | 20 | 6.69 | 0 | 3 | New | 3 | D | -16 | -6 | 3 | 4 | 0 | 3 | 21 | -10 | -56 | 50 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |